Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04669002
Title EP0057 in Combination With Olaparib in Advanced Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Ellipses Pharma

ovarian serous carcinoma

ovarian endometrial cancer

fallopian tube cancer

peritoneum cancer


NLG207 + Olaparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.